Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +62.71%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.49%
#5 Velvet Velvet +46.29%
#6 Cross Cross +37.03%
#7 Black Phoenix Black Phoenix +34.20%
#8 Cap Cap +20.04%
#9 DoubleZero DoubleZero +15.02%
#10 Humanity Humanity +11.35%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Ganga Pharmaceuticals Limited Ganga Pharmaceuticals Limited

Ganga Pharmaceuticals Limited

GANGAPHARM
Clasificación en acciones #39130
Ganga Pharmaceuticals Ltd. is actively involved in the production and trade of... Ganga Pharmaceuticals Ltd. is actively involved in the production and trade of pharmaceutical products and related goods. The company primarily concentrates on the formulation, marketing, and supply of Ayurvedic medicines in bulk quantities. Notable products in its portfolio include Ampachan Vati, Khadira Vati, and Nirmalaya Churna. The firm offers a range of Ayurvedic solutions designed to address health issues such as acidity, dandruff, oxidative stress, constipation, oral hygiene, diarrhea, ear ailments, women's health, and joint discomfort. Brijmohan C. Sharma founded the organization in 1974, and its main corporate office is located in Mumbai, India.
Precio por acción
$0.13243053
Última sincronización: 2026-03-16
Capitalización bursátil
$637.36K
Cambio (1 día)
0.00%
Cambio (1 año)
-20.46%
País
IN
Comercio Ganga Pharmaceuticals Limited (GANGAPHARM)

Categoría

Healthcare
Ganancias de Ganga Pharmaceuticals Limited (GANGAPHARM)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Ganga Pharmaceuticals Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Ganga Pharmaceuticals Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US